Objectives: We sought to evaluate the efficacy, efficiency, and physiologic consequences of automated, endpoint-directed resuscitation systems and compare them to formula-based bolus resuscitation. Design: Experimental human hemorrhage and resuscitation.
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For information regarding this article, E-mail: gabrielhundeshagen@gmail.com Closed-Loop-and Decision-Assist-Guided Fluid Therapy of Human Hemorrhage* I V fluid therapy remains the cornerstone of treating hypovolemia, but the nonsystematic use of endpoints to guide volume resuscitation efforts results in heterogeneous scientific conclusions (1) (2) (3) . Both hypovolemia and hypervolemia result in damage, dysfunction, and failure of tissue and end organs, albeit by different mechanisms (4) (5) (6) (7) . Precise fluid management is favorable to reduce sequelae of under-and over-resuscitation (6, 7) . Thus, optimizing resuscitation of hypovolemia secondary to hemorrhage remains a challenge (8) .
For hemorrhage, several teaching manuals, including the American College of Surgeons (ACS), recommends a fixedformula-based regimen that replaces 3 mL crystalloid fluid per 1 mL estimated blood loss (3:1 rule) (9) . However, most recently, the Advanced Trauma Life Support working group takes general steps toward recommending less aggressive resuscitation with lower initial volumes (10) . Still, although clinical presentation and vital signs initially influence the assessment of hypovolemic severity and recommended fluid amount, the monitoring of resuscitation success remains open ended, inconclusively defined, and subject to wide interpretation (10, 11) .
Recent concepts introduced endpoint or goal-directed volume therapy, in which fluid is titrated proportional to the measured value of a specific physiologic variable (6, 12) . Noninvasive blood pressure (NIBP) is one of the most readily accessible surrogate indicators of intravascular volume and can reliably detect hypovolemia (13) . Although NIBP has limitations, it remains the primary endpoint chosen by the ACS.
The advent of precise, portable, and reliable measuring devices also make it a promising variable for endpoint resuscitation (14) (15) (16) . Computed algorithms that analyze endpoint data and continuously adapt fluid therapy through automated infusion pumps have been tested in various animal experiments and for common resuscitation fluids (17) (18) (19) (20) .
In the present study, we assess the efficacy and efficiency of two main concepts: closed-loop (CL) resuscitation, an autonomously operating and recursive circuit of endpoint measurement and therapy adjustment and decision-assist (DA) resuscitation, which, based on endpoint measurements, recommends therapy adjustments that have to be confirmed and entered manually. We compared both systems with formulabased fluid resuscitation in humans undergoing hemorrhage.
MATERIALS AND METHODS
This study was approved by the Institutional Review Board (IRB) of the University of Texas Medical Branch at Galveston (IRB Number 07-371). Seven healthy volunteers underwent three different randomized fluid resuscitation regimens for experimentally induced hemorrhage of 10 mL/kg body weight separated by at least 4 weeks. The resuscitation regimens were as follows (Supplemental Fig. 1 The computerized algorithm for DA used a decision table linking deficit in blood pressure to infusion rate, whereas the CL algorithm used a nonlinear equation linking blood pressure to infusion rate. Both algorithms automatically administered or recommended aggressive fluid resuscitation volumes when blood pressure was furthest from target, whereas when target pressures were approached, fluid volumes were reduced toward zero to facilitate a "soft landing approach." The algorithm was developed for tight blood pressure control for head injurythus a target mean arterial pressure (MAP) of 70 mm Hg was used; we appreciate that lower MAP endpoints could also be chosen for more hypotensive resuscitation (MAP = 50 mm Hg). Figure 1 illustrates the experiment. On the day of the experiment, subject weight was recorded. A peripheral IV, arterial line and hemodynamic monitors were placed. Subjects were induced and maintained under general anesthesia (GA [T -30 = T minus 30]), while spontaneously breathing via a laryngeal mask airway (LMA, size 4 female and size 5 male). After 30 minutes of GA, 10 mL/kg of blood were removed over 20 minutes (T0-T20). After onset of hemorrhage, the respective fluid infusion was initiated. The effects of fluid resuscitation on volume spaces, hemodynamic variables, urinary output, and cardiac function were followed for 120 minutes (T120). At T120, the blood collected during the hemorrhage from the subject was reinfused over 10-20 minutes. Body weight was recorded, and the subject discharged when safety criteria were met.
GA
Propofol (2-3 mg/kg) was used to induce GA. During induction, a patent airway was confirmed and the LMA was inserted into the oral pharynx. GA was maintained with a continuous infusion of propofol (75-150 µg/kg/min). A bispectral index (BIS) monitor (Covidien, Minneapolis, MN) was used to titrate anesthesia depth to a BIS index of 50 throughout the study (21) . BIS and propofol infusion rate were recorded every 15 minutes.
Calculation of Dilution of Fluid Spaces and Volume Changes
Total fluid infused was recorded. Plasma volume (PV) was determined using an indocyanine green (Akorn, Buffalo Grove, IL) dilution and mass balance approach as previously described Change in extravascular volume (∆EVV) was calculated by subtracting changes in PV and cumulative urinary output from volume infused at each time point:
infused urinary output fluid − −
Urinary Output
As previously published, urinary output throughout the study was measured by bladder ultrasound (Bladderscan; Diagnostic Ultrasound Corporation, Bothell, WA) (24).
Blood Sampling
Baseline hemoglobin and Hct samples were taken during the stabilization period (T60 to T30) prior to GA and hemorrhage. Arterial blood samples were measured in duplicate for hemoglobin and Hct at T0, T5, T10, T15, T20, T30, T60, T90, and T120. Samples for plasma protein concentrations (total protein and albumin) to calculate colloid osmotic pressure (24) were taken at similar time points. The total blood for PV determination and for blood samples was 55 mL.
Echocardiography
End-diastolic volume (EDV) and end-systolic volume (ESV) measurements were obtained from a 3.5 MHz transducer and ultrasound system (Vivid 7 PRO BT04; GE Medical Systems, Milwaukee, WI) in twochamber, apical parasternal long-axis view at T-30, T0, T20, T60, and T120. The modified Simpson's rule was applied for calculating EDV, ESV, stroke volume, and ejection fraction.
Hemodynamic Monitoring
Specific hemodynamic measurements included MAP (measured by arterial catheter), cardiac output (CO, measured by echocardiography), heart rate (measured by electrocardiography), and systemic vascular resistance (calculated from MAP/CO × 80). All data are presented as mean ± sd unless noted otherwise. Statistical analyses were performed using GraphPad Prism version 7.00 for Windows (GraphPad Software, La Jolla, CA). Paired repeated parametric measurements were analyzed with two-way analysis of variance and Tukey's correction for multiple comparisons. Statistical significance was accepted at p value of less than 0.05.
RESULTS
DA and CL infusion reached and maintained target MAP of 70 ± 5 mm Hg after a median 15 and 10 minutes, respectively, BR after 60 minutes, without significant differences between the groups through log-rank comparison. (Fig. 2) . MAP did not decrease following initiation of CL or DA resuscitation. At 20 minutes after hemorrhage and resuscitation, MAP was significantly lower in the BR group versus CL fluid group (BR: 57 ± 2 mm Hg, CL: 69 ± 4 mm Hg; p = 0.036 (Fig. 2) . The total amount of infused fluid (Fig. 3), PV (Supplemental Fig. 3 , Supplemental Digital Content 3, http://links.lww.com/CCM/C741-legend, Supplemental Digital Content 8, http://links.lww.com/CCM/ C746), extravascular volume expansion (Fig. 4) , and urinary output ( Supplemental Fig. 4 Colloid osmotic pressure remained unchanged under DA and CL infusion and was significantly and persistently reduced following hemorrhage and resuscitation in the BR group (Fig. 5) . Systemic vascular resistance and heart rate decreased following the induction of anesthesia and hemorrhage but showed no significant differences between the groups. Echocardiographic evaluation showed a significant increase in EDV at 20 minutes (end of hemorrhage and BR resuscitation) in the BR group compared with DA and CL (BR: 143 ± 4 mL, DA: 107 ± 4 mL, CL: 120 ± 5 ml, p 
DISCUSSION
Herein, we demonstrate for the first time the efficacy and efficiency of semiautonomous (DA) and autonomous (CL) NIBPcontrolled resuscitation in a setting of human hemorrhage under GA.
Effectiveness of resuscitation is expressed by successful maintenance of vital organ perfusion in order to preserve their function. Whether a certain MAP can be restored and maintained following hemorrhage could serve as a surrogate parameter for the success of resuscitation efforts. Our systems of DA and CL infusion achieved normotensive MAP after median 10 and 15 minutes, respectively and maintained it thereafter. DA and CL systems maintained a normal PV, extravascular volume, urinary output, Hb concentration, and colloid osmotic pressure, suggesting that feedback using MAP as an endpoint adequately replaces the physiologic volume deficit over the course of resuscitation. Various clinical situations similar to our experimental approach could initially or definitively benefit from this form of endpoint-directed fluid replacement: elective or emergency surgical procedures under GA, in which estimated blood loss has been shown to be both poorly reproducible and underestimated (21, 22) ; sustained head injury, in which avoidance of hypotension is one of the most powerful predictors of outcome (23, 24) ; subclinical gastrointestinal bleeding in sedated ICU patients who require tight continuous blood pressure control and resuscitation (25) ; conservatively treated blunt abdominal trauma (26) ; or the stationary phase following initial burn shock resuscitation (27) . We assert that volume-intensive settings such as acute septic and burn shock resuscitation, penetrating trauma with substantial blood loss, uncontrolled hemorrhage of any kind, or other similar events are explicitly not a target for the specific approach we used. Nonetheless, we believe that the efficiency and simplicity of (semi) automated endpoint resuscitation can be advantageous under certain circumstances. Conservation of limited resources is of importance in field care, transportation of critically ill patients, or in an event of mass casualty. Furthermore, autonomous resuscitation systems with built-in algorithms provide the ability to export expertise. This could be advantageous in treating large numbers of patients by fewer and less experienced personnel, as required characteristically following natural disasters, terrorist attacks, or military emergencies (28) (29) (30) .
Our experimental model confirms a major shortcoming of formula-based resuscitation, in which adherence to the recommended ratio of lost-to-infused volume inevitably entails overresuscitation of smaller deficits. We demonstrate that, under formula-based 3:1 resuscitation, total volume administered, PV, extravascular volume, and urinary output are significantly increased while variables indicating hemodilution, such as Hb concentration and colloid osmotic pressure, are reduced throughout the experiment. Temporary cardiac strain, although clinically irrelevant in a population of healthy volunteers, was evident through increased EDV following bolus infusion. Interestingly, the small increase in CO for the BR group was offset by a drop in Hb, which would leave effective oxygen delivery unchanged.
The proven detrimental sequelae of fluid overload such as generalized and pulmonary edema (31, 32) , exacerbation of congestive heart failure (33), organ perfusion deficits (34) , as well as dilution of clotting factors, electrolytes, and administered medication (35) lead to increased morbidity and Cardiac output (mL) BR 5.6 ± 0. mortality in critically ill patients (36) . Therefore, the critical care community has grown increasingly sensitive to the advantages of less aggressive resuscitation approaches as proposed for instance by the Surviving Sepsis Campaign and many others (36) (37) (38) . In light of these developments, another critical and little described finding of this experiment is the further decrease in blood pressure of 10-15 mm Hg that persisted for 20 minutes after and despite administration of a large fluid bolus. We hypothesize that this effect could be mediated by capillary shear stress and nitric oxide release (39), a reduction in blood viscosity (40) , or the release of atrial natriuretic peptide following the volume-induced stretching of the atrial wall (41) . In a clinical scenario, in which ongoing resuscitation measures are based on blood pressure improvement, this paradoxical effect could induce a feedback loop in which "fluid begets more fluid" and the consequences of over infusion exacerbate.
There are limitations to this experiment. We acknowledge that few clinicians would actually resuscitate the hemorrhage volume proposed in this experiment with the recommended 3:1 infusion ratio; at the same time, we stress that ATLS continues to assert this rule regardless of hemorrhage extent (9) . Further, we wanted to test our algorithms that were designed to treat patients with traumatic brain injury and thus more aggressive as episodic hypotension worsens outcomes (23, 24) . Therefore, formula-based resuscitation was chosen as a control group for this experiment not primarily to emphasize superiority of (semi) autonomous approaches but to provide perspective toward its physiologic implications.
The use of GA itself accounted for a blood pressure decrease of 20% in all groups before hemorrhage. Blood pressure in conscious subjects does not decrease significantly enough following similar hemorrhage due to preserved compensatory sympathetic responses (42) . Furthermore, anesthesia attenuates the hemodynamic response to blood loss by increasing the unstressed venous volume, thereby reducing venous return (43) . The combination of both effects made anesthesia a unique and realistic model to study the physiology of human hemorrhage under these exact conditions. Although we did not elect to study a nonresuscitation group in the present study, we previously showed that mild hemorrhage (7 mL/kg) under GA in a similar model results in the inability to restore blood pressure to prehemorrhage levels by 120 minutes (43, 44) . Thus, we show that small amounts of fluid are needed to achieve target MAP following hemorrhage. We cannot, from current data, conclude that the observed further drop in MAP following fluid bolus administration is unrelated to anesthesia-induced dysregulation of endogenous MAP feedback control. We are thus bound to describe the effect which warrants further research.
NIBP is often deemed a non-optimal target for resuscitation and surrogate parameter for fluid load (45) . There is, however, ample evidence suggesting that noninvasively measured MAP is a better indicator of invasive blood pressure than noninvasive systolic blood pressure alone (45) (46) (47) . Although to solve this partial discrepancy is beyond the scope of this study, it has been shown recently that the difference of NIBP and invasive arterial blood pressure is clinically negligible in both adults and children with few exceptions (48, 49) ; NIBP continues to be widely used by ICU physicians (50) , and NIBP is proportional to intravascular volume during hemorrhage (12) . It is furthermore readily and feasibly available to professionals of all levels of experience and causes few complications (51) . Although blood pressure is a robust and reliable parameter for most cases, there is an age dependence regarding its readings and circumstances such as severe occlusive arterial disease, missing extremities, or mismatches between cuff and patient size may lead to erroneous readings and infusion, warranting additional caution (52) .
The concept of subjecting humans to experimental hemorrhage may seem cavalier but is well documented in the literature (53, 54) . The induced hemorrhage was large enough to produce a realistic clinical scenario of mild-to-moderate hemorrhage (up to 1 L under anesthesia) yet small enough to ensure subject safety. Nonresuscitative methods of studying volume shifts during hypovolemia in humans involve implementing lower body negative pressure (55), which does not require the physical removal of blood from subjects to simulate hypovolemia. We assert that our model offers more realistic experimental conditions as true fluid shifts occur since RBC mass is removed and actual resuscitation with realistic quantities of fluid is performed. Models of extensive hemorrhage in humans remain ethically questionable and difficult to design.
In conclusion, we believe that the gradual replacement of indiscriminate formula-based resuscitation with endpointdirected semiautonomous or autonomous infusion systems may be one means of providing standardized and individualized fluid therapy at the same time to patients undergoing hemorrhage.
